Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Kuramitsu

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Discharge Planning Update|April 9, 1991
Oregon Plan: access or rationing?Y Kuramitsu
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|May 1, 1995
[Mechanisms of enhanced accumulation of transferred LAK cells into tumor sites after chemotherapy]Y Kuramitsu
Discharge Planning Update|August 7, 1990
Health care rationingD G Brown, Y Kuramitsu
C.H.A.C. Review|May 29, 1999
New philosophy and concepts of care: the supportive care modelY Kuramitsu, S A McSkimming
Luminescence : the Journal of Biological and Chemical Luminescence|December 22, 1999
Selectivity and sensitivity in the measurement of reactive oxygen species (ROS) using chemiluminescent microspheres prepared by the binding of acridinium ester or ABEI to polymer microspheresS Hosaka, T Itagaki, Y Kuramitsu
Electrophoresis|March 22, 2000
Differential expression of phosphatidylethanol-amine-binding protein in rat hepatoma cell lines: analyses of tumor necrosis factor-alpha-resistant cKDH-8/11 and -sensitive KDH-8/YK cells by two-dimensional gel electrophoresisY Kuramitsu, M Fujimoto, T Tanaka, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1995
Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor beta by treatment with bleomycinL Yuan, Y Kuramitsu, Y Li, et al.
Anti-Cancer Drugs|March 10, 1998
A new anti-metastatic drug, ND-2001, inhibits lung metastases in rat hepatoma cells by suppressing haptotaxis of tumor cells toward lamininY Kuramitsu, J Hamada, T Tsuruoka, et al.
Anti-Cancer Drugs|December 24, 1997
The mechanism of locally enhanced production of tumor necrosis factor-alpha in tumor tissues by the administration of a new synthetic lipid A analog, ONO-4007, in hepatoma-bearing ratsY Kuramitsu, Y Ohiro, K Matsushita, et al.
Anti-Cancer Drugs|December 24, 1997
Therapeutic effects of a new synthetic lipid A analog, ONO-4007, on rat hepatoma KDH-8 depend on tumor necrosis factor-sensitivity of the tumor cellsY Kuramitsu, K Matsushita, Y Ohiro, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Discharge Planning Update|April 9, 1991
Oregon Plan: access or rationing?Y Kuramitsu
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|May 1, 1995
[Mechanisms of enhanced accumulation of transferred LAK cells into tumor sites after chemotherapy]Y Kuramitsu
Discharge Planning Update|August 7, 1990
Health care rationingD G Brown, Y Kuramitsu
C.H.A.C. Review|May 29, 1999
New philosophy and concepts of care: the supportive care modelY Kuramitsu, S A McSkimming
Luminescence : the Journal of Biological and Chemical Luminescence|December 22, 1999
Selectivity and sensitivity in the measurement of reactive oxygen species (ROS) using chemiluminescent microspheres prepared by the binding of acridinium ester or ABEI to polymer microspheresS Hosaka, T Itagaki, Y Kuramitsu
Electrophoresis|March 22, 2000
Differential expression of phosphatidylethanol-amine-binding protein in rat hepatoma cell lines: analyses of tumor necrosis factor-alpha-resistant cKDH-8/11 and -sensitive KDH-8/YK cells by two-dimensional gel electrophoresisY Kuramitsu, M Fujimoto, T Tanaka, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1995
Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor beta by treatment with bleomycinL Yuan, Y Kuramitsu, Y Li, et al.
Anti-Cancer Drugs|March 10, 1998
A new anti-metastatic drug, ND-2001, inhibits lung metastases in rat hepatoma cells by suppressing haptotaxis of tumor cells toward lamininY Kuramitsu, J Hamada, T Tsuruoka, et al.
Anti-Cancer Drugs|December 24, 1997
The mechanism of locally enhanced production of tumor necrosis factor-alpha in tumor tissues by the administration of a new synthetic lipid A analog, ONO-4007, in hepatoma-bearing ratsY Kuramitsu, Y Ohiro, K Matsushita, et al.
Anti-Cancer Drugs|December 24, 1997
Therapeutic effects of a new synthetic lipid A analog, ONO-4007, on rat hepatoma KDH-8 depend on tumor necrosis factor-sensitivity of the tumor cellsY Kuramitsu, K Matsushita, Y Ohiro, et al.
Pageof 5